Immunovia AB (publ)
IMMVF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $67,466 | $66,636 | $799,382 | $1,630,998 |
| - Cash | $25,318 | $76,788 | $106,041 | $287,406 |
| + Debt | $680 | $4,286 | $37,574 | $33,262 |
| Enterprise Value | $42,828 | -$5,866 | $730,915 | $1,376,854 |
| Revenue | $931 | $1,575 | $1,145 | $844 |
| % Growth | -40.9% | 37.6% | 35.7% | – |
| Gross Profit | $931 | -$5,107 | -$3,066 | $15,813 |
| % Margin | 100% | -324.3% | -267.8% | 1,873.6% |
| EBITDA | -$61,265 | -$148,462 | -$141,579 | -$135,471 |
| % Margin | -6,580.6% | -9,426.2% | -12,365% | -16,051.1% |
| Net Income | -$76,541 | -$309,439 | -$168,092 | -$155,966 |
| % Margin | -8,221.4% | -19,646.9% | -14,680.5% | -18,479.4% |
| EPS Diluted | -0.93 | -7.95 | -6.89 | -6.4 |
| % Growth | 88.3% | -15.4% | -7.7% | – |
| Operating Cash Flow | -$96,753 | -$147,057 | -$175,582 | -$152,648 |
| Capital Expenditures | $0 | -$1,061 | -$1,624 | -$24,184 |
| Free Cash Flow | -$96,753 | -$148,118 | -$177,206 | -$176,832 |